Rewriting the rules of infusion therapy

Research, case studies, and insights advancing patient experience and employer savings.

Specialty infusion has quietly become one of the most expensive, least transparent categories in employer health spend, and most benefits and finance leaders have never seen what's actually driving the cost.

This is where we break it down: the claims data behind buy-and-bill markup, the patient stories behind every savings number, and the questions employers should be asking their carrier before the next renewal.

Explore the research and real member outcomes shaping a more transparent path to specialty care.